M&A Deal Summary

Pfizer Acquires Alacer

On February 27, 2012, Pfizer acquired consumer products company Alacer

Acquisition Highlights
  • This is Pfizer’s 2nd transaction in the Consumer Products sector.
  • This is Pfizer’s 16th transaction in the United States.
  • This is Pfizer’s 6th transaction in California.

M&A Deal Summary

Date 2012-02-27
Target Alacer
Sector Consumer Products
Buyer(s) Pfizer
Deal Type Add-on Acquisition
Advisor(s) Houlihan Lokey (Financial)

Target

Alacer

Foothill Ranch, California, United States
Alacer Corp. makes and distributes Emergen-C products, a branded Vitamin C line in the United States. It produces almost 500 million packets of Emergen-C annually, and its products are sold in health food stores, supermarkets, drug stores, mass merchandisers and club stores across the US.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Pfizer

New York, New York, United States

Category Company
Founded 1849
Sector Life Science
Employees8,300
Revenue 58.5B USD (2023)
DESCRIPTION
Pfizer office in Lake Forest, Illinois.
Pfizer office in Lake Forest, Illinois.

Pfizer is a global pharmaceutical company that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare products, including medicines and vaccines. The company's portfolio includes treatments across a broad spectrum of areas such as oncology, cardiology, neurology, and infectious diseases, among others. Pfizer was founded in 1849 and is based in New York, New York.


DEAL STATS #
Overall 19 of 44
Sector (Consumer Products) 2 of 2
Type (Add-on Acquisition) 16 of 31
State (California) 6 of 14
Country (United States) 16 of 32
Year (2012) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-11-22 Excaliard Pharmaceuticals

Carlsbad, California, United States

Excaliard is a private biotechnology company focused on the development and commercialization of antisense drugs for the local treatment of scarring and other fibrotic diseases.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-10-22 NextWave Pharmaceuticals

Cupertino, California, United States

NextWave Pharmaceuticals is a specialty pharmaceutical company developing extended release OTC and prescription products for children and adults. NextWave Pharmaceuticals was founded in 2005 and is based in Cupertino, California.

Buy $700M